Now that our study has highlighted the potential importance of purinergic signaling in lupus, future studies should consider parallel/compensatory pathways such as CD38/CD203a, as well as adenosine deaminase (62, 63), in both mice and humans. This evidence concerns the gene CD38 and systemic lupus erythematosus.